Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Fresenius Kabi USA, LLC | Grand Island, NY, United States | Makes it and tests it | Problems found, fixed voluntarilyOct 13, 2023 · 14 inspections, 2 with FDA action |
Recalls
- Apr 5, 2016 · Class II · Fresenius Kabi USA, LLC
Incorrect/ Undeclared Excipient: Firm is recalling product due to an incorrect statement of Preservative free on the individual carton label. The vial label and outer carton label contain the correct statement of 0.9% benzyl alcohol added as a preservative.
Lots: Lot #: 6010157, Exp. 01/2017
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Cisatracurium: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 2 mg per 1 mL
- Approval
- ANDA ANDA203183
- On the market since
- Feb 26, 2015
- Package NDCs
63323-417-0163323-417-10- Official label
- DailyMed (National Library of Medicine), updated Feb 21, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?